Company Filing History:
Years Active: 2009-2011
Title: Stephanie Knieps: Innovator in Metabolic Disorder Treatments
Introduction
Stephanie Knieps is a prominent inventor based in Sulzbach, Germany. She has made significant contributions to the field of metabolic disorder treatments, particularly focusing on conditions such as hyperlipidemia and diabetes. With a total of 3 patents to her name, her work is recognized for its innovative approach to addressing insulin-related metabolic disorders.
Latest Patents
Stephanie's latest patents include groundbreaking compounds and compositions aimed at treating metabolic disorders. One of her notable inventions is a series of 2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives. These compounds serve as peroxisome proliferator-activated receptor (PPAR) ligands, which are essential for the treatment of hyperlipidemia and diabetes. The invention encompasses acetic acid derivatives with cyclohexylmethoxy substituents and their salts, providing a novel approach to managing insulin-related metabolic disorders.
Another significant patent involves arylcycloakyl-substituted alkanoic acid derivatives, which are also useful as PPAR ligands for treating similar metabolic disorders. This invention highlights the potential of these compounds in addressing blood-related insulin issues, further solidifying Stephanie's role as a key innovator in this field.
Career Highlights
Stephanie Knieps is currently employed at Sanofi-Aventis Deutschland GmbH, where she continues to develop her research and innovations. Her work has been instrumental in advancing the understanding and treatment of metabolic disorders, making her a valuable asset to her company and the scientific community.
Collaborations
Throughout her career, Stephanie has collaborated with notable colleagues, including Heiner Glombik and Christian Stapper. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of metabolic health.
Conclusion
Stephanie Knieps stands out as a dedicated inventor whose work in metabolic disorder treatments is paving the way for new therapeutic options. Her contributions are vital in the ongoing battle against conditions like hyperlipidemia and diabetes, showcasing her commitment to improving health outcomes.